Jupiter Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Jupiter Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,855	Closed	-$280K	–	603
2022 Q2	$280K	Buy	+9,855	New	+$312K	﹤0.01%	533

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Jupiter Asset Management's MRVI Position: Q3 2022 in Review

Jupiter Asset Management sold out of Maravai LifeSciences (MRVI) in Q3 2022, closing a stake of 9,855 shares — an estimated $280K sold.

Jupiter Asset Management first reported a position in MRVI in Q2 2022 and held it in 1 quarter. The position peaked at $280K in Q2 2022. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2022.

Jupiter Asset Management reported no remaining Maravai LifeSciences position as of Q3 2022 after selling out during the quarter.
Jupiter Asset Management sold 9,855 Maravai LifeSciences shares in Q3 2022, an estimated $280K.
Jupiter Asset Management first reported a position in Maravai LifeSciences in Q2 2022 and held it in 1 quarter.
Jupiter Asset Management's Maravai LifeSciences position peaked at $280K in Q2 2022.
202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2022.

Based on Jupiter Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.